EUVIMEDEUVIMED entdecken
Crossref

Discovery and Characterization of a Cereblon-Based Degrader for PTP1B and TCPTP

Zihan Qu, Yunpeng Bai, Jinmin Miao, Jiajun Dong, Zheng Zhang iD, Yiming Miao, Frederick Nguele Meke, Benjamin Babalola iD, Momen Al-Hindy, Bo Huang, Jingmei Yu iD, W Andy Tao iD und 1 weitere

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.6c01484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Zihan Qu und 12 weiteren Autor:innen. Beteiligte Einrichtung: James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, West Lafayette, Indiana47907, United States. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 1, Protein Tyrosine Phosphatase, Non-Receptor Type 2, Enzyme Inhibitors, Drug Discovery. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Purdue University, NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein tyrosine phosphatase 1B (PTP1B) and T cell protein tyrosine phosphatase (TCPTP) play non-redundant roles in regulating T cell activation and tumor antigen presentation, making them compelling cancer immunotherapy targets. Recent studies have illustrated the viability of concomitant PTP1B/TCPTP degradation as a promising strategy to drug these proteins. Herein, using a phosphonodifluoromethyl phenylalanine (F2Pmp)-based dual PTP1B and TCPTP inhibitor, we report a cereblon (CRBN)-based small molecule degrader X1 targeting both phosphatases with improved potency, selectivity, and plasma exposure after intraperitoneal administration. X1 enhances T cell receptor (TCR) signaling in T cells and IFNγ-mediated JAK1/2-STAT1 activation in tumor cells, promoting surface MHC-I antigen presentation. X1 alone or combined with anti-PD-1 treatment exhibits robust anti-tumor efficacy in a syngeneic tumor model by increasing T cell infiltration and activation. These findings highlight the translational potential of systemic and concomitant targeting of both PTP1B and TCPTP as a promising strategy for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 1Protein Tyrosine Phosphatase, Non-Receptor Type 2Enzyme InhibitorsDrug DiscoveryAntineoplastic AgentsAnimalsHumansMiceT-Lymphocytes

Stichwörter der Autor:innen

PROTAC degraderPTP1BT-cell activationTCPTPimmunotherapyincreased antigen presentation

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 1Protein Tyrosine Phosphatase, Non-Receptor Type 2PTPN1 protein, humanEnzyme InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, West Lafayette, Indiana47907, United States.
  • Department of Biochemistry, Purdue University, West Lafayette, Indiana47907, United States.
  • Institute for Cancer Research, Purdue University, West Lafayette, Indiana47907, United States.
  • Institute for Drug Discovery, Purdue University, 720 Clinic Drive, West Lafayette, Indiana47907, United States.

ORCID-Profile: Zheng Zhang, Benjamin Babalola, Jingmei Yu, W Andy Tao, Zhong-Yin Zhang

Förderung

  • Purdue University
  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Qu, Z., Bai, Y., Miao, J., Dong, J., Zhang, Z., Miao, Y., Meke, F. N., Babalola, B., Al-Hindy, M., Huang, B., Yu, J., Tao, W. A., & Zhang, Z. Y. (2026). Discovery and Characterization of a Cereblon-Based Degrader for PTP1B and TCPTP. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01484

Vancouver

Qu Z, Bai Y, Miao J, Dong J, Zhang Z, Miao Y, et al. Discovery and Characterization of a Cereblon-Based Degrader for PTP1B and TCPTP. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01484

BibTeX
@article{Qu2026,
  author = {Qu, Zihan and Bai, Yunpeng and Miao, Jinmin and Dong, Jiajun and Zhang, Zheng and Miao, Yiming and Meke, Frederick Nguele and Babalola, Benjamin and Al-Hindy, Momen and Huang, Bo and Yu, Jingmei and Tao, W Andy and Zhang, Zhong-Yin},
  title = {Discovery and Characterization of a Cereblon-Based Degrader for PTP1B and TCPTP},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c01484}
}
Kostenlos starten →